Xtant Medical Holdings, Inc.

AMEX:XTNT

Medical - Devices

Healthcare
$0.36 -0.16%

-$0.00 today

Market cap
$50.37M
Beta
-0.17
P/E (TTM)
33.4
EPS (TTM)
$0.01
52W Low $0.40High $0.95

Volume 0.16M

Average 0.16M

XTNT Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

Xtant Medical Holdings, Inc.AMEX: XTNT

Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026

Net change in cash grows, but more slowly than its trailing trend

Q1 FY2026 net change in cash of $5.17M (cash outflow) rose 557.9% year over year, behind the +728.9% change in trailing-twelve-month net change in cash. Over 3 fiscal years it compounded at +73.7% a year.

Context

  • Net change in cash amounted to 8.3% of revenue in FY2025, up 8.0 pp from a year earlier.
  • Net change in cash increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +557.9% toward the trailing-twelve-month pace of +728.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$5.17M-177.3% QoQ
Last fiscal yearDec 2025
$11.11M+3627.2% YoY
LTMMar 2026
$6.72M+728.9% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+557.9%——
1 year+3627.2%——
3-year CAGR+73.7%——
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
11.11M USD
Year-over-year change
+3627.2%
4-year CAGR
-8.8%

Net Change in Cash vs competitors

How XTNT compares with its peers on the latest reported figures

  • XTNT's LTM Mar 2026 net change in cash of $6.72M is the 3rd largest of the 8 companies compared; the peer median is $607K.
  • Its year-over-year change of +728.9% is the highest of 8, against a peer median of +102.0%.
  • Net change in cash amounts to 5.5% of revenue for XTNT, versus a peer median of 9.1%.
XTNT Competitors Peer median
Net Change in Cash for XTNT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EXOZeXoZymes, Inc.LTM Mar 2026$7.07M -184.2%——
VANIVivani Medical, Inc.LTM Mar 2026$6.74M +140.5%——
XTNTXtant Medical Holdings, Inc.LTM Mar 2026$6.72M +728.9%+73.7%5.5%
RCELAVITA Medical, Inc.LTM Mar 2026$6.56M +215.3%-53.4%9.1%
RPIDRapid Micro Biosystems, Inc.LTM Mar 2026$5.09M +47.7%—14.8%
LUCDLucid Diagnostics Inc.LTM Mar 2026$2.64M +462.5%—51.4%
FONRFONAR CorporationLTM Mar 2026$607K -320.6%—0.6%
APYXApyx Medical CorporationLTM Mar 2026$126K +102.0%-96.4%0.2%
Peer median (excluding XTNT) $607K+102.0%-74.9%9.1%

Competitors are the stored peer set for XTNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(4.85M)(8.49M)660K(16.45M)4.97M
Depreciation & Amortization1.33M1.29M3.17M4.22M5.22M
Deferred Income Tax00(1.9M)21K0
Stock-Based Compensation2.21M2.46M2.74M4.12M2.89M
Change in Working Capital793K(2.81M)(3.63M)(5.35M)(3.05M)
Accounts Receivables(319K)(3.94M)(8.74M)(755K)(591K)
Inventory2.62M(1.15M)(1.89M)(2.49M)(2M)
Accounts Payables(332K)875K2.98M1.03M(3.12M)
Other Working Capital(1.18M)1.41M4.01M(3.13M)2.66M
Other Non-Cash Items954K2.2M(10.55M)1.54M2.5M
Operating Cash Flow439K(5.34M)(9.52M)(11.9M)12.55M
Capital Expenditures(2.12M)(1.76M)(1.46M)(4.11M)(2.38M)
Acquisitions (Net)00(23.5M)00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities225K205K175K383K10.28M
Investing Cash Flow(1.89M)(1.56M)(24.78M)(3.73M)7.9M
Debt Repayment(592K)(291K)6.18M12.43M(9.33M)
Common Stock Issued18.43M9.31M14.01M4.46M0
Common Stock Repurchased0000(65K)
Dividends Paid00000
Other Financing Activities(337K)9.07M(500K)(816K)(175K)
Financing Cash Flow17.5M9.02M19.69M16.07M(9.57M)
Effect of Forex Changes0024K(149K)232K
Net Change in Cash16.05M2.12M(14.58M)298K11.11M
Free Cash Flow(1.68M)(7.11M)(10.97M)(16.01M)10.16M

Xtant Medical Holdings, Inc.

AMEX:XTNT

Intrinsic Alpha fair value

Locked

Current Price

$0.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.